H William Kelly
Overview
Explore the profile of H William Kelly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelly H
Pediatr Allergy Immunol Pulmonol
. 2022 Aug;
24(1):51-53.
PMID: 35927851
Anticholinergics have been used for the treatment of asthma as bronchodilators for centuries, yet they have not gained U.S. Food and Drug Administration approval for use in asthma. Previous studies...
2.
Lee S, Won H, Kim B, Kim S, Chang Y, Cho S, et al.
Sci Rep
. 2019 Dec;
9(1):20133.
PMID: 31882850
Derangement in bone mineral density (BMD) caused by glucocorticoid is well-known. The present study aimed to find key biological pathways associated with low BMD after glucocorticoid treatment in asthmatics using...
3.
Guilbert T, Bacharier L, Mauger D, Phipatanakul W, Szefler S, Boehmer S, et al.
J Allergy Clin Immunol
. 2019 Jan;
143(5):1934-1937.e4.
PMID: 30660645
No abstract available.
4.
Busse W, Bateman E, Caplan A, Kelly H, OByrne P, Rabe K, et al.
N Engl J Med
. 2018 Jun;
378(26):2497-2505.
PMID: 29949492
Background: Safety concerns regarding long-acting β-agonists (LABAs) in asthma management were initially identified in a large postmarketing trial in which the risk of death was increased. In 2010, the Food...
5.
Oppenheimer J, Kelly H
Ann Allergy Asthma Immunol
. 2017 Dec;
119(6):473-474.
PMID: 29223295
No abstract available.
6.
Raissy H, Kelly H
Paediatr Drugs
. 2017 Aug;
19(6):533-538.
PMID: 28808948
Evidence is emerging on the use of long-acting muscarinic antagonists (LAMAs) in the management of asthma. Tiotropium bromide (Spiriva Respimat) is the only LAMA approved in children and adolescents. As...
7.
8.
Raissy H, Kelly H
Drug Saf
. 2016 Dec;
40(3):201-210.
PMID: 27928727
International guidelines provide recommendations for a stepwise approach to the management of asthma in children 0-4 years old, 5-11 years old, and adolescents who are treated as adults. Therapy is...
9.
Raissy H, Timmins G, Davies L, Heynekamp T, Harkins M, Sharp Z, et al.
Pediatr Allergy Immunol Pulmonol
. 2016 Jul;
29(2):68-73.
PMID: 27458537
This is a "proof of concept" study to determine whether inhalation of C-urea can be safely used to detect the presence of urease producing bacteria in the airways of patients...
10.
McGeachie M, Yates K, Zhou X, Guo F, Sternberg A, Van Natta M, et al.
Am J Respir Crit Care Med
. 2016 Jul;
194(12):1465-1474.
PMID: 27367781
Rationale: Patterns of longitudinal lung function growth and decline in childhood asthma have been shown to be important in determining risk for future respiratory ailments including chronic airway obstruction and...